WeConnectPatients.com · Blood & Immune Health

Your body is fighting the wrong battle. And you deserve more than just watching your numbers.

ITP is a blood condition where your immune system destroys your own platelets — the cells that help you stop bleeding. It’s real, it’s treatable, and you’re not in this alone.

Per 100K Annually

New cases diagnosed each year in North America

Report Fatigue

The most common symptom — often worse than the bleeding

Women Affected

Chronic ITP is significantly more common in women

Active Research

As of early 2026, a growing number of clinical trials are studying new ITP treatment approaches

Your immune system is destroying your platelets. That’s what ITP means.

ITP isn’t something you caused. It’s not stress. It’s not a vitamin deficiency. Your immune system made an error — and your platelets are paying the price.

Platelets are tiny blood cells that rush to the scene when you cut yourself. They clump together and help you stop bleeding. In ITP, your immune system tags your platelets for destruction before they can do their job.

The result? Bruises that show up without explanation. Nosebleeds that won’t quit. Tiny red or purple pinpoint dots on your skin called petechiae — caused by small amounts of bleeding just under the surface. Or sometimes, nothing visible at all — just a low number on a blood test that changes everything.

ITP affects people across every age, race, and background. Research has shown that outcomes can vary by race and access to care — which is one reason why inclusive clinical trials and equitable access to treatment matter. Kids often get a short-lived form after a virus. Adults tend to develop chronic ITP that sticks around and requires ongoing management.

Here’s what matters most: ITP is more than a platelet count. The fatigue, the anxiety, the cognitive load of constantly monitoring your own body, the way you start avoiding anything that might cause a bruise — that’s all part of it. And it should all factor into your care.

What drives ITP

Your immune system is the central player. But several factors can set the stage or trigger a flare.

Autoimmune misfiring

Your immune system produces antibodies that attach to your platelets and mark them for destruction. Your spleen and liver then clear these tagged platelets from your blood far too quickly. It’s friendly fire — and your body doesn’t know how to stop.

Viral triggers

Infections can kick-start ITP, especially in children. Viruses like Epstein-Barr, cytomegalovirus, or even a common cold can confuse the immune system into attacking platelets. This happens through a process called molecular mimicry — where viral proteins are similar enough to platelet proteins that the immune system attacks both by mistake.

Gender and hormones

Women develop chronic ITP 2 to 3 times more often than men. The reasons aren’t fully understood, but autoimmune conditions in general affect women disproportionately. Pregnancy and hormonal changes can also complicate platelet counts.

Medications and other conditions

Certain drugs can trigger ITP. Helicobacter pylori infection, hepatitis C, and other autoimmune conditions like lupus are also associated. Your doctor should look at the full picture.

It’s not your fault

ITP is not caused by diet, lifestyle, or anything you did wrong. You didn’t bring this on. It’s an immune system error — and modern medicine has real tools to address it.

How ITP is diagnosed

ITP is a diagnosis of exclusion. There’s no single test that confirms it — your doctor rules out other causes first.

Complete blood count

A simple blood test reveals low platelets. Normal range is 150,000 to 400,000 per microliter. Below 100,000 with otherwise normal blood cells raises the flag for ITP.

Blood smear

A technician looks at your blood under a microscope. In ITP, the platelets are low but the ones present look normal or larger than usual. No abnormal cells.

Rule out other causes

Your doctor checks for infections, medication effects, liver disease, and other autoimmune conditions that could explain the low count. This step is critical.

Assess your symptoms

Platelet counts don’t always match how you feel. Some people bleed at 50,000. Others are fine at 10,000. Your doctor should ask about bruising, fatigue, bleeding, and how ITP is affecting your daily life.

Check the whole picture

Good ITP care means screening for related conditions. Fatigue, anxiety, depression, and quality of life should all be part of the conversation from day one.

Treatment has changed dramatically

The goal today isn’t just raising your platelet count — it’s giving you a life that doesn’t revolve around a number.

First Line

Corticosteroids

Steroids like prednisone are usually the first step. They work fast — studies report initial response in 70 to 80% of people, though responses are often not sustained with long-term use. And long-term use brings real side effects: weight gain, mood changes, bone loss, infection risk. Most doctors want you off steroids as quickly as possible.

Second Line

TPO Receptor Agonists (Thrombopoietin Receptor Agonists)

These medications stimulate your bone marrow to produce more platelets. Oral and injectable options are available. Studies have reported response rates of 80 to 85% (based on published clinical data), and TPO receptor agonists have transformed how chronic ITP is managed. For many people with chronic ITP, they represent a significant improvement in long-term management.

Targeted Therapy

Rituximab and Beyond

For people who don’t respond to steroids or TPO receptor agonists, rituximab targets specific immune cells involved in platelet destruction. Initial response rates are reasonable, but relapse within 1–2 years is common — your hematologist can help you weigh the benefits and duration of effect. Splenectomy — removing the spleen — remains an option with long-term success in a meaningful proportion of patients. Newer immunosuppressives are available for especially difficult cases.

Emerging Science

What’s Coming Next

Researchers are targeting the root cause of ITP: the rogue immune cells that attack your platelets. Therapies in this category — including agents that block antibody recycling, complement inhibitors, and precision immunotherapies targeting specific immune cells — are an active area of development. Some have received regulatory approval in recent years, while others are being evaluated in clinical trials. Talk to your hematologist about which newer options may apply to your situation.

All treatments carry potential side effects. Talk to your provider about which risks and benefits apply to you.

“The worst part wasn’t the bruises. It was the exhaustion — and nobody talked about it until I brought it up myself.”

Reflects common patient experiences

If cost is a barrier, ask about patient assistance programs. ITP medications can be expensive, but pharmaceutical assistance programs, insurance advocacy, and clinical trials can help bridge the gap.

Answers to common questions

Living with ITP raises real, practical questions. Here are honest answers to some of the most common ones.

Is the fatigue real, or is it in my head?

It’s real. The iWISh survey found 58% of ITP patients report fatigue at diagnosis, and nearly half still have it even when their platelet counts are under control. Fatigue is the symptom patients most want addressed — but it’s often the last thing doctors bring up. Bring it up yourself.

How do I stop obsessing over my platelet count?

This is one of the hardest parts. Your number can swing wildly between tests, and it’s easy to tie your entire emotional state to it. Work with your hematologist to set a personalized target range, not a single magic number. And talk to a therapist if the anxiety is running the show.

Can I still exercise and be active?

Usually, yes. Your hematologist will guide you based on your count, but most people with counts above 30,000–50,000 can be moderately active. You may need to avoid contact sports or activities with high injury risk. The goal is to live your life, not avoid everything out of caution.

Does ITP affect mental health?

Yes, it can. Anxiety, depression, and a constant low-grade worry about bleeding are common. Parents of children with ITP often experience their own form of trauma. Mental health is a medical issue, not a character flaw. Ask your care team for a referral.

Will I need treatment forever?

It depends. Some adults achieve lasting remission. Others need ongoing management. The unpredictability is one of the hardest things about ITP. But treatment options keep expanding, and researchers are actively working on approaches that could lead to treatment-free remission.

What about pregnancy with ITP?

It requires careful planning with both your hematologist and OB-GYN. Platelet counts can drop during pregnancy, and some treatments aren’t safe for the baby. But many women with ITP have healthy pregnancies. The key is early coordination.

How do I explain ITP to people who don’t get it?

Keep it simple: “My immune system destroys my platelets — the cells that help blood clot. It causes bruising, fatigue, and bleeding. It’s not contagious, and it’s not something I can control.” You don’t owe anyone more than that.

Are there support communities?

The Platelet Disorder Support Association (PDSA) is the main advocacy organization. Online communities on Facebook and Reddit have active ITP groups. Connecting with people who understand the constant platelet-count anxiety makes a real difference.

Research & Progress

The science is advancing steadily

ITP research is advancing steadily. Scientists now understand that it’s not just about antibodies destroying platelets — it involves complex immune system dysfunction including T-cell problems, complement activation, and bone marrow suppression. That deeper understanding is opening doors to entirely new types of treatment.

The past several years have brought new regulatory approvals in ITP for the first time in over a decade — an important milestone for the field. If you haven’t revisited your treatment options with your hematologist recently, it’s worth asking what’s new.

What’s in the pipeline: medications that block how your body recycles the antibodies that attack platelets. Therapies targeting the complement system. Precision treatments aimed at the specific immune cells causing damage. And studies looking at whether certain patients can safely stop treatment entirely and stay in remission.

Clinical trials are how these treatments reach people who need them. Participating gives you access to specialized hematology teams and emerging therapies while contributing to better care for everyone with ITP. There’s no obligation. Your standard care continues regardless.

You deserve a care plan that goes beyond the numbers. Not just a platelet count to chase.

ITP research is opening new doors. Whether you’ve been managing this for years or you were just diagnosed, there may be options worth exploring.

Not sure where to start?

Walking into a hematology appointment with the right questions changes everything. We put together a quick guide.

This content is for educational purposes only and isn’t a substitute for medical advice. Talk to your healthcare provider before making decisions about your care. Information about clinical trials is for general awareness, not an endorsement of any specific study.

Sources: NCBI/StatPearls, PMC, PubMed, iWISh survey, Blood Journal, Blood Advances, Haematologica, Taylor & Francis, Annals of Blood, ScienceDirect, ClinicalTrials.gov, peer-reviewed literature (2018–2026).

WeConnect is a Takeda initiative connecting people to clinical trial opportunities. Visit WeConnectPatients.com.